Microbot Medical Inc. (MBOT)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Microbot Medical Inc. (MBOT) is up 0.5% since the beginning of the year. At $2 per share, MBOT is trading 57.0% below its 52-week high of $5. Investors who bought $1,000 worth of MBOT shares 5 years ago would now be looking at an investment worth $267.

Microbot Medical Inc. (MBOT) has returned 0.50% so far this year and -24.72% over the past 12 months. Over the last ten years, MBOT has returned -12.65% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.

Based on dividend-adjusted daily data since Mar 25, 1992, MBOT's average daily return is +0.20%, while the average monthly return is +4.05%. At this rate, an investment would double in approximately 1.5 years.

Historically, 40% of months were positive and 60% were negative. The best month was Nov 2016 with a return of +948.5%, while the worst month was May 2016 at -85.9%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 8 months.

On a daily basis, MBOT closed higher 40% of trading days. The best single day was Aug 16, 2016 with a return of +598.6%, while the worst single day was May 31, 2016 at -81.2%.

Microbot Medical Inc. has an annualized alpha of 51.87%, beta of 0.84, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since March 26, 1992.

• This stock participated in 173.25% of S&P 500 Index downside but only 29.57% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

MBOT ranks 29 for risk / return — below 29% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for Microbot Medical Inc. (MBOT) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Microbot Medical Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Microbot Medical Inc. was 100.00%, occurring on Sep 4, 2024. The portfolio has not yet recovered.

The current Microbot Medical Inc. drawdown is 99.99%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Microbot Medical Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Microbot Medical Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.